182 related articles for article (PubMed ID: 37994572)
21. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
22. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
23. Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
Chatzistamatiou K; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Skenderi A; Stamatopoulos K; Agorastos T
Gynecol Oncol; 2021 Sep; 162(3):560-568. PubMed ID: 34210517
[TBL] [Abstract][Full Text] [Related]
24. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
[No Abstract] [Full Text] [Related]
25. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
[TBL] [Abstract][Full Text] [Related]
26. Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.
Gori S; Battagello J; Gustinucci D; Campari C; Zorzi M; Frayle H; Passamonti B; Sartori G; Bulletti S; Fodero C; Cesarini E; Faggiano R; Del Mistro A
BJOG; 2021 Jul; 128(8):1353-1362. PubMed ID: 33326680
[TBL] [Abstract][Full Text] [Related]
27. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic value of multiply biopsies and endocervical curettage on cervical lesions].
Zhang L; Du H; Zhang W; Yang B; Wang C; Belinson JL; Wu R
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):263-7. PubMed ID: 26080937
[TBL] [Abstract][Full Text] [Related]
29. Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program.
Sahlgren H; Elfström KM; Lamin H; Carlsten-Thor A; Eklund C; Dillner J; Elfgren K
Am J Obstet Gynecol; 2020 Mar; 222(3):253.e1-253.e8. PubMed ID: 31585095
[TBL] [Abstract][Full Text] [Related]
30. Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis.
Kipp B; Ulrich E; van Meegen C; Schwenzer T
BMC Infect Dis; 2024 Jun; 24(1):558. PubMed ID: 38834951
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results.
Wright TC; Stoler MH; Sharma A; Zhang G; Behrens C; Wright TL;
Am J Clin Pathol; 2011 Oct; 136(4):578-86. PubMed ID: 21917680
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
33. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
[TBL] [Abstract][Full Text] [Related]
34. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
[TBL] [Abstract][Full Text] [Related]
35. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of cytology and visual triage of human papillomavirus-positive women in cervical cancer prevention in India.
Muwonge R; Wesley RS; Nene BM; Shastri SS; Jayant K; Malvi SG; Thara S; Sankaranarayanan R
Int J Cancer; 2014 Jun; 134(12):2902-9. PubMed ID: 24272364
[TBL] [Abstract][Full Text] [Related]
37. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy.
Schneider A; Hoyer H; Lotz B; Leistritza S; Kühne-Heid R; Nindl I; Müller B; Haerting J; Dürst M
Int J Cancer; 2000 Nov; 89(6):529-34. PubMed ID: 11102899
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of combined molecular and morphology-based triage for HPV-positive women in routine cervical cancer screening services from Colombia.
Murillo R; Gamboa O; Hernández G; González M; Olejua P; Molano M; Wiesner C
Prev Med; 2021 Dec; 153():106801. PubMed ID: 34508733
[TBL] [Abstract][Full Text] [Related]
39. Is cervical cytology testing as a part of co-test unnecessary for HPV 16/18-infected women? A retrospective cohort study of 1647 women.
Giray B; Kabaca C; Uzun MG; Akis S; Purut YE; Peker EK; Cetiner H
Diagn Cytopathol; 2021 Feb; 49(2):267-272. PubMed ID: 33006823
[TBL] [Abstract][Full Text] [Related]
40. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
